Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| BAM | 8-K | neutral | 2/10 | BAM filed an 8-K announcing a revision to its presentation of non-GAAP metrics (Fee Revenues, Fee-Related Earnings, Fee- | Sep 28, 2026 |
| GTY | 8-K | bullish | 6/10 | Getty Realty Corp. closed a $260.9 million sale-leaseback acquisition of 41 convenience stores from Refuel Operating Com | Sep 28, 2026 |
| KOD | 8-K | bullish | 7/10 | Kodiak Sciences announced positive topline Phase 3 DAYBREAK results for both Zenkuda (tarcocimab tedromer) and tabirafus | Sep 28, 2026 |
| LFCR | 8-K | bullish | 8/10 | Lifecore Biomedical has entered into a definitive merger agreement to be acquired by an affiliate of Webster Equity Part | Sep 28, 2026 |
| CMT | 8-K | neutral | 2/10 | Core Molding Technologies promoted Michael J. Gayford to Chief Operating Officer, effective September 28, 2026. This is | Sep 28, 2026 |
| QMCO | 8-K | neutral | 3/10 | Quantum Corporation appointed James C. Clancy as Chief Operating Officer, effective September 28, 2026. Clancy, a former | Sep 28, 2026 |
| PKE | 8-K | neutral | 2/10 | Park Aerospace Corp. filed an 8-K reporting that the Compensation Committee approved an increase in the annual base sala | Sep 28, 2026 |
| FUL | 8-K | neutral | 3/10 | H.B. Fuller announced the resignation of director Ruth S. Kimmelshue and the appointment of R. Jeffrey Bailly to the Boa | Sep 28, 2026 |
| SLXN | 8-K | neutral | 4/10 | Silexion Therapeutics reported positive preclinical in vitro findings for its lead siRNA candidate SIL204, demonstrating | Sep 28, 2026 |
| BMNR | 8-K | bullish | 6/10 | Bitmine Immersion Technologies announced its crypto, cash, and marketable securities holdings total $17.2 billion as of | Sep 28, 2026 |
| GLND | 8-K | neutral | 2/10 | Greenland Energy Co filed an 8-K announcing the successful completion of its government-approved 2026 environmental base | Sep 28, 2026 |
| BHRB | 8-K | neutral | 4/10 | Burke & Herbert Financial Services Corp. filed a preliminary prospectus supplement for a $100 million offering of Fixed- | Sep 28, 2026 |
| SVAQ | 8-K | neutral | 4/10 | SVAQ, a SPAC, entered into a third amendment to its business combination agreement with EigenQ, Inc. The amendment exclu | Sep 28, 2026 |
| MDB | 8-K | mixed | 6/10 | MongoDB CEO Chirantan (CJ) Desai resigned to join Meta Platforms, effective immediately. Former CEO Dev Ittycheria was a | Sep 28, 2026 |
| GPK | 8-K | neutral | 2/10 | Graphic Packaging filed an 8-K to furnish a Fall 2026 Corporate Governance and Stewardship presentation for investor mee | Sep 28, 2026 |
| DFDV | 8-K | neutral | 4/10 | DeFi Development Corp. announced it added 47,706 SOL to its treasury during the week ending September 25, 2026, bringing | Sep 28, 2026 |
| PSKY | 8-K | mixed | 7/10 | Paramount Skydance Corp. filed an 8-K announcing the launch of approximately $44.4 billion in senior secured note offeri | Sep 28, 2026 |
| CYCU | 8-K | mixed | 5/10 | Cycurion terminated its Equity Purchase Agreement with Yield Point NY LLC for convenience, removing a potential equity f | Sep 28, 2026 |
| BEAG | 8-K | bullish | 7/10 | Bold Eagle Acquisition Corp. (BEAG) has entered into a definitive business combination agreement to acquire REDL Interme | Sep 28, 2026 |
| RNAZ | 8-K | bullish | 6/10 | TransCode Therapeutics reported updated Phase 1a clinical data for TTX-MC138, showing a 71.4% stable disease rate in 14 | Sep 28, 2026 |
| ACET | 8-K | bullish | 7/10 | Adicet Bio reported positive Phase 1 safety and efficacy data for prula-cel (formerly ADI-001), an allogeneic gamma delt | Sep 28, 2026 |
| FATE | 8-K | bullish | 5/10 | Fate Therapeutics received a $15 million CLIN2 grant from the California Institute for Regenerative Medicine (CIRM) to s | Sep 28, 2026 |
| SOAR | 8-K | bullish | 7/10 | Volato Group's Alignment Engine subsidiary signed two four-year, take-or-pay orders with a large AI customer totaling ap | Sep 28, 2026 |
| BGC | 8-K | neutral | 3/10 | BGC Group filed an 8-K on September 28, 2026, reaffirming its previously stated Q3 2026 outlook ranges for revenue and p | Sep 28, 2026 |
| MIRM | 8-K | bullish | 7/10 | Mirum Pharmaceuticals announced FDA approval of Atebrioz (zilurgisertib) for FOP and positive Phase 3 AZURE-1 data for b | Sep 28, 2026 |
| LCCC | 8-K | neutral | 3/10 | Lakeshore Acquisition III Corp. (LCCC) received the third extension payment of $67,500 from merger partner CPRO Electron | Sep 28, 2026 |
| KROS | 8-K | neutral | 4/10 | Keros Therapeutics announced the first patient was dosed in its Phase 2 clinical trial of rinvatercept for Duchenne musc | Sep 28, 2026 |
| SHFS | 8-K | neutral | 4/10 | SHF Holdings announced a 1-for-12 reverse stock split, effective September 30, 2026, to regain compliance with Nasdaq li | Sep 28, 2026 |
| AIMD | 8-K | bullish | 5/10 | Ainos entered into a global exclusive license agreement with BioPhoenix Co., Ltd. for its VELDONA low-dose oral interfer | Sep 28, 2026 |
| MTNB | 8-K | neutral | 4/10 | Matinas BioPharma filed a Certificate of Amendment to effect a 1-for-15 reverse stock split, effective September 28, 202 | Sep 28, 2026 |